Evidence map›Paper›PMID 29190932›Full record

ArticleOncotarget2017

Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients.

Theresa Benezeder, Verena Tiran, Alexandra A N Treitler, Christoph Suppan, Christopher Rossmann, Herbert Stoeger, Richard J Cote, Ram H Datar, Marija Balic, Nadia Dandachi

Abstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Review
  3. Methylation-regulated tumor suppressor geneTranslational cancer research · 2025
    Article
  4. Review
  5. Potential Role ofClinical Medicine Insights. Oncology · 2024
    Article
  6. Review
  7. Review
  8. Impact ofPharmacogenomics and personalized medicine · 2022
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Methylation inCells · 2020
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Theresa BenezederMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.
Verena TiranMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.
Alexandra A N TreitlerMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.
Christoph SuppanMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.
Christopher RossmannMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.
Herbert StoegerMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.
Richard J CoteUniversity of Miami Miller School of Medicine, Department of Pathology, Miami, Florida, U.S.A.
Ram H DatarUniversity of Miami Miller School of Medicine, Department of Pathology, Miami, Florida, U.S.A.
Marija BalicMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.
Nadia DandachiMedical University of Graz, Department of Internal Medicine, Division of Oncology, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood-based biomarkers such as circulating tumor cells (CTCs) provide dynamic real-time assessment of molecular tumor characteristics beyond the primary tumor. The aim of this study was to evaluate the feasibility of a size-based microfilter to assess multigene methylation analysis of enriched CTCs in a prospective proof-of principle study. We examined the quantitative methylation status of nine genes (

Indexed as

circulating tumor cellsenrichmentmetastatic breast cancermethylationprognosis

Identifiers

PMID29190932
PMCPMC5696198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.